Replies to post #582523 on NorthWest Biotherapeutics Inc (NWBO)
04/02/23 8:54 PM
04/02/23 9:08 PM
04/02/23 9:09 PM
Critical review of the report on the DCvax-L trial: the trial did not meet its prospectively defined endpoint and post-hoc analyses with poorly selected external controls do not replace a proper prospective trial https://t.co/3kJnHYW4P6
— Martin van den Bent (@MartinvdenBent) December 23, 2022
Critical review of the report on the DCvax-L trial: the trial did not meet its prospectively defined endpoint and post-hoc analyses with poorly selected external controls do not replace a proper prospective trial https://t.co/3kJnHYW4P6
— Martin van den Bent (@MartinvdenBent) December 23, 2022
04/02/23 9:16 PM
https://t.co/q8sm3ax4yp pic.twitter.com/pEz7aBVVv0
— Blake (@MC17595091) April 3, 2023
04/03/23 9:38 AM
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |